Task order 1A: project kick-off meeting and task order 2A: ctsu core support services & the ctsu enterprise of systems; cancer trials support unit (ctsu) IDIQ

Active Awarded Last action

Contract number
75N91022F00001
Awardee
Awarding agency
Obligated
$97,248,696

Award facts

Opportunity
Contract value 45% obligated
  • $98,259,375.00 Current, with exercised options
  • $214,450,401.00 Potential, with all options
Completion date 42% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00010 $20,600,000
Exercise an Option P00009 $20,000,000
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Exercise an Option P00006 $19,713,281
Other Administrative Action P00005 $0
Exercise an Option P00004 $18,500,000
Exercise an Option P00003 $2,168,703
Exercise an Option P00002 $2,190,022
Other Administrative Action P00001 $0
Original award $14,076,690
Show all 11

About this award

The National Cancer Institute issued delivery orders (Task Order 1A: Project Kick-Off Meeting and Task Order 2A: CTSU Core Support Services) to Westat, Inc. on August 1, 2022, with a ceiling value of $214.45 million and ultimate completion date of July 31, 2032, under the Cancer Trials Support Unit IDIQ for cancer trials coordination and enterprise system support services.

Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with no set-aside applied. Service Contract Inventory data reflects a labor footprint that scaled from 7.6 FTEs invoiced in FY2022 ($849 thousand at $53.98/hr) to 155 FTEs in FY2023 ($17.8 million at $55.38/hr), dropped to near-zero activity in FY2024, then returned to 154 FTEs in FY2025 ($21.4 million at $66.69/hr across 320,474 contractor hours). Blended hourly rates show an upward trend. In FY2025, subcontractors accounted for approximately 6 percent of contractor hours through three named subcontractors.

Quick answers

Who was awarded contract 75N91022F00001?

75N91022F00001 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2022.

How much is contract 75N91022F00001 worth?

The government has obligated $97,248,696 on 75N91022F00001. Its current value, with exercised options, is $98,259,375. Its potential value, with all options, is $214,450,401.

Is contract 75N91022F00001 an order under another contract?

Yes. 75N91022F00001 is a delivery order under 75N91022D00009, an indefinite delivery contract, on Cancer Trials Support Unit.

Was contract 75N91022F00001 competed?

The extent of competition for 75N91022F00001 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award